Differences in Regulatory Frameworks Governing Genetic Laboratories in Four Countries

Authors

  • Anne Marie Tassé,

    1. Lawyer and a research associate at the Bioethics Program, Department of Preventative and Social, Medicine, Faculty of Medicine, University of Montreal.
    Search for more papers by this author
  • Élodie Petit,

    1. Ethics consultant and a lecturer at the Bioethics Program, Department of Preventative and Social, Medicine, Faculty of Medicine, University of Montreal.
    Search for more papers by this author
  • Béatrice Godard

    1. Associate Professor and Director Bioethics Programs, Department of Preventative and Social Medicine, Faculty of Medicine, University of Montreal, Montreal, Quebec.
    Search for more papers by this author

Abstract

The purpose of this article is to determine how the heterogeneity of the different regulatory frameworks governing genetic laboratories in Australia, France, the United Kingdom, and the United States hinder the international availability of genetic tests. We conclude that a better understanding of the various national standards governing genetic laboratories may help health professionals choose laboratories for referral in an evidence based manner in order to protect the patient's best interests.

Ancillary